Photo: Depositphotos
Jun 23, 2025, 08:19
Anwaar Saeed: STELLAR-303 as First IO Trial Showing OS Benefit in MSS Colorectal Cancer
Anwaar Saeed, Associate Professor and Chief of Gastrointestinal Medical Oncology at the University of Pittsburgh, shared a post on X:
“STELLAR-303 makes history! First-ever Ph3 trial to show OS benefit of IO in MSS CRC.
Years of grit and belief led us here.
Endless thanks to Exelixis for the trust and Dr. Hecht for leading this global win with me!”
More posts featuring Colon Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 23, 2025, 15:18
Jun 23, 2025, 11:18
Jun 23, 2025, 10:55
Jun 23, 2025, 09:19
Jun 23, 2025, 08:55